Post Page Advertisement [Top]

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...
http://dlvr.it/RrZ4TC

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
Copyright 2017, Dbc Khabar. All rights Reserved.
| Designed by Colorlib